Hemalini Mehta is a Rheumatology/Immunology physician affiliated with Clinical Research Institute. OpenAlex indexes 16 publications with 469 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Nicollet Mall
Suite 1149
Minneapolis, MN 554022606
Telephone
612-338-3333Registry record last updated 2 Feb 2010.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20256 payments
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- Baxter HealthcareProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
92.4%Corticosteroid47.1%Breo Ellipta35%Fluticasone Propionate24%Qvar Redihaler11%Fluticasone Propionate Hfa9%Arnuity Ellipta9%Pulmicort Flexhaler6%Symbicort6%Part D<11 patientsLeukotriene Receptor Antagonist23.3%Montelukast Sodium100%Part D≥22 patients+ 2 more classes in this area
Metabolism & gastrointestinal
4.3%Corticosteroid4.3%Prednisone100%Part D≥16 patientsAnti-infectives
3.3%Macrolide Antimicrobial3.3%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)
The Journal of Allergy and Clinical Immunology In Practice
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”